The Pfizer Strategy: How AI and Culture Are Rewriting Medicine
Pfizer CEO Albert Bourla discusses the transformation of the pharmaceutical giant through scientific focus, AI integration, and a culture of resilience. He details the strategic rationale behind major acquisitions like Seagen, the necessity of AI literacy for organizational agility, and the competitive threat posed by China’s rapid advancements in biotech. Bourla emphasizes that leadership is defined by optimism, authenticity, and the ability to foster a culture that 'eats strategy for lunch.'